1. Home
  2. NNI vs DYN Comparison

NNI vs DYN Comparison

Compare NNI & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nelnet Inc.

NNI

Nelnet Inc.

HOLD

Current Price

$132.53

Market Cap

4.6B

Sector

Finance

ML Signal

HOLD

DYN

Dyne Therapeutics Inc.

HOLD

Current Price

$24.27

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNI
DYN
Founded
1978
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.6B
3.9B
IPO Year
2003
2020

Fundamental Metrics

Financial Performance
Metric
NNI
DYN
Price
$132.53
$24.27
Analyst Decision
Hold
Strong Buy
Analyst Count
1
14
Target Price
$140.00
$37.00
AVG Volume (30 Days)
107.1K
2.3M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
0.93%
N/A
EPS Growth
134.86
N/A
EPS
1.97
N/A
Revenue
N/A
N/A
Revenue This Year
$2.28
N/A
Revenue Next Year
$5.38
N/A
P/E Ratio
$66.88
N/A
Revenue Growth
N/A
N/A
52 Week Low
$116.62
$8.25
52 Week High
$144.38
$25.00

Technical Indicators

Market Signals
Indicator
NNI
DYN
Relative Strength Index (RSI) 53.12 74.87
Support Level $128.04 $16.47
Resistance Level $133.36 N/A
Average True Range (ATR) 2.41 1.19
MACD 0.09 0.37
Stochastic Oscillator 57.51 99.07

Price Performance

Historical Comparison
NNI
DYN

About NNI Nelnet Inc.

Nelnet Inc is a United States based company engaged in these four reportable segments; Loan Servicing and Systems, which focuses on student and consumer loan origination services and servicing, loan origination and servicing-related technology solutions, and outsourcing business services; Education Technology Services and Payments segment provides education services, payment technology, and community management solutions for K-12 schools, institutions, churches, and businesses; Asset Generation and Management segment includes the acquisition and management of student and other loan assets; and Nelnet Bank focuses on the private education and unsecured consumer loan markets. Maximum revenue for the company is generated from its Asset Generation and Management.

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease being treated, a linker, and an antigen-binding fragment that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.

Share on Social Networks: